Press Release (ePRNews.com) - Aurora, Illinois - Sep 21, 2017 - Stem cell injections are now used for soft tissue injuries and defects with amniotic fluid based treatments.
In the past couple of years, stem cell therapy has been brought to the forefront of medicine. Most therapy is done through a technique called Platelet Rich Plasma, better known as PRP. This technique is drawing the patients own blood and running it through a centrifuge to collect the available cells in the blood. After collection and processing, the concentrated blood is re-injected into the designated site for therapy. PRP therapy usually consists of a series of injections, approximately 3, over a designated time-frame.
While this therapy has some success, there are some drawbacks with this technique. The number of stem cells possible with the technique is much less than what is available with other injection substances. Also, adult cells do not always maintain the potential to differentiate into all types of human tissue, such as cartilage, muscle, tendon, and bone.
Each person is born with a level of stem cells in their body. At birth, the stem cell level is at its’ peak with about 1 in 10,000 cells. This level progressively declines with age. As a teenager, the number drops to 1 in 100,000 cells. At age thirty it continues downwards to 1 in 250,000 cells. At age fifty the amount is 1 in 400,000 and finally, by the age eighty, it is a paltry 1 in 2,000,000.
Stem cell injections are the next evolution in regenerative medicine. Not only does the fluid contain an immense amount of stem cells, it also contains a whole biological system that adds to the benefits. The amniotic cell fluid has been shown to be a rich source of proteins, growth factors and multipotent cells essential for fetal growth and development. Medical research demonstrates that the presence of these cells provides ancillary clinical benefits by enhancing the body’s natural regenerative process while filling soft tissue defects.
No fetal tissue exists in amniotic fluid, avoiding the ethical concerns of embryonic cells while maintaining the existence of multipotent cells. These cells still are undifferentiated and have the capacity to change into cartilage, bone, or muscle cells. Embryonic cells may overdo it and form too many cells creating tumors, while the stem cells in the amniotic fluid do not have this quality.
The current medical literature demonstrates that cytokines, growth factors, hyaluronic acids and stem cells present in amniotic tissue and fluid stimulate the repair of tissues or modulate the local microenvironment by enhancing the body’s natural regenerative process and potentially allow damaged tissue to undergo regeneration. For more details on regenerative treatment, visit chicagolandmedical.com
Chicagoland Medical is committed to helping as many people as possible to get and stay well, utilizing a natural first approach. Working with the Chicagoland Medical, patients will receive thorough and comprehensive treatment that seeks to cure the root of the problem and not just the symptoms. Source :